Banced Corp’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-5,247
Closed -$548K 119
2017
Q4
$548K Buy
5,247
+1,145
+28% +$129K 0.91% 40
2017
Q3
$598K Sell
4,102
-495
-11% -$67.4K 1.04% 27
2017
Q2
$597K Buy
4,597
+4
+0.1% +$490 1.1% 30
2017
Q1
$571K Sell
4,593
-17
-0.4% -$2.03K 1.04% 31
2016
Q4
$534K Sell
4,610
-340
-7% -$37.9K 1.01% 39
2016
Q3
$517K Buy
+4,950
New +$536K 1.01% 33

Other funds holding CELG

Banced Corp's CELG Position: Q1 2018 in Review

Banced Corp sold out of Celgene Corp (CELG) in Q1 2018, closing a stake of 5,247 shares — an estimated $548K sold.

Banced Corp first reported a position in CELG in Q3 2016 and held it in 6 quarters. The position peaked at $598K in Q3 2017. 1,397 funds tracked by Wall St. Rank hold CELG as of Q1 2018.

  • Banced Corp reported no remaining Celgene Corp position as of Q1 2018 after selling out during the quarter.
  • Banced Corp sold 5,247 Celgene Corp shares in Q1 2018, an estimated $548K.
  • Banced Corp first reported a position in Celgene Corp in Q3 2016 and held it in 6 quarters.
  • Banced Corp's Celgene Corp position peaked at $598K in Q3 2017.
  • 1,397 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2018.

Based on Banced Corp's 13F filing for Q1 2018, filed 9 Apr 2018.